Emerging Role of Gut Microbiota in Breast Cancer Development and Its Implications in Treatment

• Published in: Metabolites 2024-12, Vol.14 (12), p.683
• Main Authors: Mir, Rashid, Albarqi, Shrooq A, Albalawi, Wed, Alatwi, Hanan E, Alatawy, Marfat, Bedaiwi, Ruqaiah I, Almotairi, Reema, Husain, Eram, Zubair, Mohammad, Alanazi, Ghaida, Alsubaie, Shouq S, Alghabban, Razan I, Alfifi, Khalid A, Bashir, Shabnam
• Format: Article
• Language: English
• Subjects: Bacteria; Breast cancer; Cancer; cancer immunotherapy; Cancer therapies; Cardiovascular diseases; Development and progression; Diabetes mellitus; Digestive system; Disease prevention; Dysbacteriosis; dysbiosis; Estrogen; Gastrointestinal tract; gut microbiota; Health aspects; hormone metabolism; Hormones; Immune response; Inflammation; Intestinal microflora; Metabolites; Microbiomes; Microbiota; Microbiota (Symbiotic organisms); Oncology, Experimental; Prevention; Probiotics; Review; Rheumatoid arthritis; Rheumatoid factor; Tumor microenvironment
• ISSN: 2218-1989; 2218-1989
• DOI: 10.3390/metabo14120683

The human digestive system contains approximately 100 trillion bacteria. The gut microbiota is an emerging field of research that is associated with specific biological processes in many diseases, including cardiovascular disease, obesity, diabetes, brain disease, rheumatoid arthritis, and cancer. Emerging evidence indicates that the gut microbiota affects the response to anticancer therapies by modulating the host immune system. Recent studies have explained a high correlation between the gut microbiota and breast cancer: dysbiosis in breast cancer may regulate the systemic inflammatory response, hormone metabolism, immune response, and the tumor microenvironment. Some of the gut bacteria are related to estrogen metabolism, which may increase or decrease the risk of breast cancer by changing the number of hormones. Further, the gut microbiota has been seen to modulate the immune system in respect of its ability to protect against and treat cancers, with a specific focus on hormone receptor-positive breast cancer. Probiotics and other therapies claiming to control the gut microbiome by bacterial means might be useful in the prevention, or even in the treatment, of breast cancer. The present review underlines the various aspects of gut microbiota in breast cancer risk and its clinical application, warranting research on individualized microbiome-modulated therapeutic approaches to breast cancer treatment.